Pascal Soriot

French businessman

13 stories

18 quotes

We believe it can be more than 5 billion, simply because the unmet need is huge,
Tozorakimab is a product nobody thought would work. We ourselves had a very low probability of success,
We continue to invest at pace in our transformative technologies and in our commercial execution to bring our innovative medicines to patients around the globe and drive growth beyond 2030.”
We have to accept to fail some of the time,
We need to understand their priorities and where the priorities are,
We remain confident in the strength of our pipeline and have more than twenty high-value readouts due over the next 18 months,

Earlier